Sign in
Taking peopleNo phase

Following people with jaw bone damage linked to certain medicines

Follows adults with medication-related osteonecrosis of the jaw to see what affects recovery.

Key facts

Who runs it
Marmara University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Therapeutic Exposures and Risk Factors in MRONJ
Status
Recruiting
People taking part
250 people, planned
Started
25 Apr 2024
Expected to end
26 Apr 2027
Type of study
Observational
Record updated
28 May 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with jaw bone damage caused by medicines (MRONJ). They must come to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery during the study period.

Age
18 Years to 110 Years
Sex
All sexes can join
Disease stage
Medication-related osteonecrosis of the jaw: jaw bone damage linked to certain medicines.

Main reasons for not taking part

  • Jaw bone damage or bone infection not caused by medicines
  • Jaw bone damage caused by radiation (osteoradionecrosis)
  • Cancer that has spread to the mouth area
  • No written consent from the person or their legal representative
  • Under 18 years of age

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Individuals aged 18 and over
  • Male or female individuals
  • Individuals who apply to the Marmara University Faculty of Dentistry, Department of Oral and Maxillofacial Surgery due to medication-related osteonecrosis of jaw during the study period
  • Individuals or their legal representatives who have given written consent to participate in the study

Who cannot take part

  • Non-drug-related osteonecrosis/osteomyelitis
  • Individuals under the age of 18
  • Osteoradionecrosis
  • Metastasis to the oral region
  • Individuals who have not given written consent to participate in the study

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 110 years old?

This trial is currently available in Türkiye.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Identification of Therapeutic Exposures and Risk Factors Associated With Medication-Related Osteonecrosis of the Jaw
Plain-language title
Following people with jaw bone damage linked to certain medicinesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06430762, who can take part
Record updated
28 May 2024